SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota. Show more

Location: 11495 Valley View Road, Eden Prairie, MN, 55344, United States | Website: https://sanuwave.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

284.6M

52 Wk Range

$24.80 - $39.50

Previous Close

$36.16

Open

$35.86

Volume

38,277

Day Range

$33.06 - $36.13

Enterprise Value

299.5M

Cash

8.501M

Avg Qtr Burn

-40.5K

Insider Ownership

6.25%

Institutional Own.

29.35%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date